Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis (ExSiMS)

January 5, 2026 updated by: Martin Ballegaard MD PhD, Zealand University Hospital

Effects of Aerobic Exercise and Daytime Sleep on Neurorehabilitation and Functional Abilities in Multiple Sclerosis: Evidence of Training the Brain in Neurorehabilitation

The ExSiMS study is a randomized, controlled crossover study including 20 individuals (18-70 years) diagnosed with relapsing remitting Multiple Sclerosis (MS) This project investigates, through behavioral and neurophysiological measurements, how aerobic exercise on an ergometer bike and sleep in the form of a nap and overnight sleep may enhance cortical motor skill learning evaluated by a complex hand motor skill test and thereby improve functional capacity in individuals with MS. Beyond the effect on motor skill learning, the project investigate the effect on electroencephalography (EEG) - electromyography (EMG) coherence.

The study hypothesizes that individuals with neurological conditions, such as multiple sclerosis (MS), may experience beneficial effects on specific motor rehabilitation through systematically planned cardiovascular exercise and sleep scheduling, due to positive impacts on memory consolidation.

Aims:

  • Investigate the brain's neurophysiological responses and memory effects following a training intervention and, separately, sleep, in the form of a power nap, in individuals with MS.
  • Examine whether these effects persist beyond the few days previously observed in healthy individuals by implementing a longer-term intervention.
  • Explore whether the training effect is influenced by disease activity in the brain, such as during relapses and during immunosuppressive treatment.
  • Assess whether the presence of abnormally reduced cognitive endurance (fatigue) affects the impact of the intervention involving exercise and sleep.

The study is based on documented positive effects of physical activity and sleep in both young and older adults, as well as in individuals recovering from stroke. The research thus offers promising perspectives for broader applications within neurorehabilitation, and particularly for MS, as the disease is associated with functional impairments. At the same time, both physical exercise and sleep represent meaningful interventions that should be thoughtfully integrated into rehabilitation strategies.

Study Overview

Detailed Description

The ExSiMS-project consists of both a proof-of-concept study and a longitudinal study.

In both studies, participants will perform a visuomotor accuracy tracking task (VATT) with their dominant hand on the main experimental days. The participants will wear EEG and EMG electrodes during the VATT. This will make it possible to investigate cortical activity during skill acquisition and later analyse the corticomuscular coherence. After the VATT, the participants will be randomized to either 20 min aerobic exercise on an ergometer bike, a short 30-minute nap or control (sitting rest). The interventions will run over a longer period of time in the longitudinal study.

The participants will be asked to do a retention test of the visuomotor accuracy tracking task 24 hours later.

The studies will run over more experiment days divided into two experiment blocks of at least two experiment days separated by between two weeks to three months.

Methods:

  • Electroencephalography (EEG) and Electromyography (EMG)
  • Actigraphy/Accelerometry
  • Visuomotor Accuracy Tracking Task (VATT)
  • Training on an Ergometerbike: Graded Exercise Test (GXT), High Intensity Interval Training (HIIT)
  • Polysomnography (PSG)

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Copenhagen, Denmark, 2200
        • Not yet recruiting
        • Section of Movement and Neuroscience, Department of Nutrition, Exercise, and Sports, University of Copenhagen
        • Contact:
        • Contact:
      • Roskilde, Denmark, 4000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Competent individuals (aged 18-70) diagnosed with early relapsing-remitting MS
  • Expanded Disability Status Score, 1 < EDSS < 4.5
  • MRC muscle strength ≥ 4+ in the dominant hand

Exclusion Criteria:

  • Implanted devices, such as pacemakers or stimulators
  • Epilepsy or neuromuscular diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic Exercise - GXT
The aerobic exercise will consist of about 20 minutes of Graded Exercise Training (GXT) on an ergometer bike. The experimenter will instruct and motivate the participant through the aerobic exercise.
The Aerobic Exercise Intervention consists of 20 minutes of Graded Exercise Test (GXT) on an ergometer bike. The participants start with 5 minutes of warm-up. The wattload will then be increased until exhaustion.
No Intervention: Control - Rest
The participant will rest in a sitting position in a quiet room for 20 minutes. The participant is allowed to read or engage in similar quiet and sitting activities.
Experimental: Daytime Sleep - Nap
The participants will be asked to try and take a 30-minute nap. The participant will be provided with a bed in a dark and quiet room.
The Daytime sleep consists of a 30-minute nap after the acquisition of the visuomotor accuracy tracking task. The participants will be asked to rest in a supine position in a bed in a dark and quiet room.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor/Skill Learning
Time Frame: Assessed on experiment days 1, 2, 3 and 4.
Visuomotor accuracy tracking task. Online and offline effects. Unit: Range from 0 (lowest) to 100 (highest) percent.
Assessed on experiment days 1, 2, 3 and 4.
Neurophysiological Measurement I - Cortical Activity
Time Frame: Assessed on experiment day 1, 2, 3 and 4.
Cortical activity will be measured with electroencephalography (EEG) during skill acquisition. Unit: EEG Power in several frequency bands.
Assessed on experiment day 1, 2, 3 and 4.
Neurophysiological Measurement II - Muscular Activity
Time Frame: Assessed on experiment day 1, 2, 3 and 4.
Muscle activity will be measured with electromyography (EMG) during skill acquisition. Unit: EMG amplitude.
Assessed on experiment day 1, 2, 3 and 4.
Neurophysiological Measurement III - Corticocortical Functional Connectivity
Time Frame: Assessed on experiment day 1, 2, 3 and 4.
Corticocortical functional connectivity will me measured as functional coupling in EEG during skill acquisition. Unit: functional coupling in EEG (scale 0-1).
Assessed on experiment day 1, 2, 3 and 4.
Neurophysiological Measurement IV - Corticomuscular Functional Connectivity
Time Frame: Assessed on experiment day 1, 2, 3 and 4.
Corticomuscular functional connectivity during skill acquisition will be measured with functional coupling between EEG and EMG. Unit: functional coupling in EEG-EMG.
Assessed on experiment day 1, 2, 3 and 4.
Neurophysiological Measurement V - Muscular Functional Connectivity
Time Frame: Assessed on experiment day 1, 2, 3 and 4.
Muscular functional connectivity during skill acquisition will be assessed using EMG-EMG coherence between M. Abductor Pollicis Brevis and First Dorsal Interosseus. Unit: EMG-EMG coherence (0-1)
Assessed on experiment day 1, 2, 3 and 4.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Actigraphy
Time Frame: Assessment from day 0 to experiment day 4.
Measurement of sedentary, moderate, and vigorous activity during the experiment period. Unit = hours:min.
Assessment from day 0 to experiment day 4.
Sleep quality - self reported sleep latency.
Time Frame: Assessed at the days leading up to experiment days 1,2,3, and 4.
Self-reported sleep latency will be measured by the National Sleep Foundation Sleep Diary translated to Danish. Unit: Hour:minutes.
Assessed at the days leading up to experiment days 1,2,3, and 4.
Sleep quality - Self reported sleep duration
Time Frame: Assessed at the days leading up to experiment days 1,2,3, and 4.
Self-reported sleep duration will be measured by the National Sleep Foundation Sleep Diary translated to Danish. Unit: Hour:min.
Assessed at the days leading up to experiment days 1,2,3, and 4.
Physical fitness level - work load
Time Frame: Assessed on either experiment day 1 or 3.
Graded exercise test (GXT) on an ergometer bike - maximum work load. Unit: watt
Assessed on either experiment day 1 or 3.
Physical fitness level - heart rate
Time Frame: Assessed on either experiment day 1 or 3
Graded exercise test (GXT) on an ergometer bike - heart rate measured with a chest strap. Unit: beats per minute (BPM).
Assessed on either experiment day 1 or 3
Physical fitness level - rating of perceived exertion
Time Frame: Assessed on either experiment day 1 or 3.
Graded exercise test (GXT) on an ergometer bike - rating of perceived exertion with the Borg scale. Unit: Borg scale 6-20 (6 = rest, 20 = maximal exhaustion).
Assessed on either experiment day 1 or 3.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wakefulness
Time Frame: Assessed on experiment days 1, 2, 3 and 4.
Wakefulness will be measured by the Stanford Sleepiness Scale: From 1 to 7. 1= "Feeling active and vital; alert; wide awake". 7= "Almost in reverie; sleep onset soon; lost struggle to remain awake. X = Asleep".
Assessed on experiment days 1, 2, 3 and 4.
Handedness
Time Frame: Assessed on day 0.
Handedness questionnaire to determine the participant's dominant hand. Unit: Laterality index (-100.00 (lefthanded) to 100.00 (righthanded).
Assessed on day 0.
Reaction Time Task
Time Frame: Assessed on day 0.
A simple Reaction Time Task on a computer. Unit: ms.
Assessed on day 0.
The fatigue scale for motor and cognitive functions (FSMC)
Time Frame: Assessed on day 0.
Questionnaire measuring fatigue in individuals with Multiple Sclerosis. Unit: FSMC_total = Points from 20-100 (≥ 43 Mild Fatigue, ≥ 53 Moderate Fatigue, ≥ 63 Severe Fatigue).
Assessed on day 0.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Martin Ballegaard, Zealand University Hospital - Roskilde

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

November 30, 2028

Study Registration Dates

First Submitted

November 26, 2025

First Submitted That Met QC Criteria

December 11, 2025

First Posted (Estimated)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

January 8, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Aerobic Exercise

Subscribe